Valuation : Pathkey.AI Ltd

Market Cap 4.32Cr 3.1Cr 2.67Cr 2.53Cr 2.29Cr 4.3Cr 296.09Cr 30Cr 12Cr 150.64Cr 12Cr 11Cr 476Cr P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 3.98Cr 2.85Cr 2.46Cr 2.33Cr 2.11Cr 3.96Cr 272.73Cr 28Cr 11Cr 138.75Cr 11Cr 10Cr 438.44Cr EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
1 week-8.57%
Current month-21.95%
1 month-13.51%
3 months-40.74%
6 months+28.00%
Current year+100.00%
1 week 0.03
Extreme 0.032
0.04
1 month 0.03
Extreme 0.032
0.05
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-8.57%+14.29%-36.00% 3.1Cr
+0.54%-4.61%-5.08%+21.63% 4.25TCr
-1.51%-5.52%-44.93%+127.19% 1.23TCr
-0.28%-1.52%-10.90%+75.78% 568.69Cr
+9.65%+1.98%+49.43% - 433.72Cr
+2.14%-4.09% - - 201.77Cr
+1.67%-4.60%+3.02%-38.62% 149.57Cr
+0.89%-4.85%-36.83% - 104.27Cr
0.00%-0.58%+14.80%+152.22% 101.3Cr
-2.09%-5.21%+34.13%+37.70% 88Cr
Average +1.10%-3.58%+1.99%+48.56% 713.07Cr
Weighted average by Cap. +0.71%-4.04%-8.73%+47.64%

Financials

2025 2026
Net sales 3L 2L 2L 2L 2L 3L 2.21Cr 22.38L 9L 1.12Cr 9L 8L 3.55Cr 47.63T 34.16T 29.43T 27.87T 25.26T 47.39T 32.64L 3L 1L 16.6L 1L 1L 52.47L
Net income -14.48L -10.38L -9L -8L -8L -14.4L -9.92Cr -1.01Cr -38.69L -5.05Cr -39L -38.14L -16Cr -36.53L -26.2L -22.57L -21.37L -19.37L -36.34L -25Cr -2.54Cr -97.61L -13Cr -98.39L -96.23L -40Cr
Net Debt -25.17T -18.05T -15.55T -14.72T -13.35T -25.04T -17.24L -2L -67.25T -9L -67.79T -66.3T -27.72L -34.1L -24.46L -21.07L -19.95L -18.08L -33.93L -23Cr -2.37Cr -91.12L -12Cr -91.84L -89.83L -38Cr
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
11/26/11 A$0.0320 0.00% 20,28,451
10/26/10 A$0.0320 -8.57% 43,60,007
09/26/09 A$0.0350 -7.89% 40,57,828
08/26/08 A$0.0380 +2.70% 6,86,346
07/26/07 A$0.0370 +5.71% 30,88,249
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!